ISSN 0303-5212
 
2026, Vol: 51, Issue: 2
51 / 2Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Author_Certificate-old
Bank Reciept

Original Research
Online Published: 17 May 2016
 
RMJ. 2016; 41(2): 160-165


Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan

Muhammad Hammas Adil, Ayisha Ghufran, Abid Zaheer Farooqi.


Abstract
Objectives: To assess the effectiveness and safety of rituximab (RTX) and the predictors of its response at 24 weeks in patients with rheumatoid arthritis (RA).
Methodology: The study included 61 Pakistani patients, who had active RA despite treatment with conventional disease modifying anti rheumatic drugs (cDMARDs). They were given RTX and followed for 24 weeks. Change in the 28-joint Disease Activity Score (DAS28) and the proportions of patients achieving disease remission according to the European League Against Rheumatism (EULAR) response criteria were used to assess the effectiveness at week 24 (primary analysis) and week 48 (exploratory analysis). Adverse events were also recorded.
Results: The mean DAS28 score significantly decreased from 6.27 to 3.67 at week 24 and was maintained at 4.07 at week 48. 91.5% patients had a moderate or good EULAR response at week 24, which persisted in 90.3% of the patients at week 48. Effectiveness was unaffected regardless of rheumatoid arthritis factor, status, gender, age, disease duration and concurrent use of methotrexate or leflunomide. Majority of adverse events were seen during first infusion and were mild, other than 2 anaphylactic reactions and a myocardial infarction. At the 24 week follow-up, one patient had herpes zoster and one had upper respiratory infection, while three had worsening of existing hypertension.
Conclusions: RTX is a safe and effective drug in Pakistani patients with active RA, providing a sustained improvement in disease symptoms in majority of the patients.

Key words: Rituximab, rheumatoid arthritis, DMARD, methotrexate


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Muhammad Hammas Adil
Articles by Ayisha Ghufran
Articles by Abid Zaheer Farooqi
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Adil MH, Ghufran A, Farooqi AZ. Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan. RMJ. 2016; 41(2): 160-165.

Web Style

Adil MH, Ghufran A, Farooqi AZ. Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan. https://www.rmj.org.pk/?mno=217983 [Access: June 27, 2026].

AMA (American Medical Association) Style

Adil MH, Ghufran A, Farooqi AZ. Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan. RMJ. 2016; 41(2): 160-165.


Vancouver/ICMJE Style

Adil MH, Ghufran A, Farooqi AZ. Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan. RMJ. (2016), [cited June 27, 2026]; 41(2): 160-165.


Harvard Style

Adil, M. H., Ghufran, . A. & Farooqi, . A. Z. (2016) Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan. RMJ, 41 (2), 160-165.


Turabian Style

Adil, Muhammad Hammas, Ayisha Ghufran, and Abid Zaheer Farooqi. 2016. Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan. Rawal Medical Journal, 41 (2), 160-165.


Chicago Style

Adil, Muhammad Hammas, Ayisha Ghufran, and Abid Zaheer Farooqi. "Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan." Rawal Medical Journal 41 (2016), 160-165.


MLA (The Modern Language Association) Style

Adil, Muhammad Hammas, Ayisha Ghufran, and Abid Zaheer Farooqi. "Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan." Rawal Medical Journal 41.2 (2016), 160-165. Print.


APA (American Psychological Association) Style

Adil, M. H., Ghufran, . A. & Farooqi, . A. Z. (2016) Effectiveness and safety of rituximab in patients with active rheumatoid arthritis treated at a tertiary care hospital in Pakistan. Rawal Medical Journal, 41 (2), 160-165.


Author LoginReviewer LoginEditorial PoliciesConflict of Interest PolicyPlagiarism PolicyAdvertising Policy

About Rawal Medical Journal

Publication, subscription and Editorial office PMA House G/220-B Liaquat Road, Rawalpindi. Phone: 051-555-9812, Fax: 051-553-7088 Email: drnkhokhar@ya ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information